Cargando…

Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method

[Image: see text] Protein–ligand interactions are essential to drug discovery and drug development efforts. Desirable on-target or multitarget interactions are the first step in finding an effective therapeutic, while undesirable off-target interactions are the first step in assessing safety. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevenson, Garrett A., Kirshner, Dan, Bennion, Brian J., Yang, Yue, Zhang, Xiaohua, Zemla, Adam, Torres, Marisa W., Epstein, Aidan, Jones, Derek, Kim, Hyojin, Bennett, W. F. Drew, Wong, Sergio E., Allen, Jonathan E., Lightstone, Felice C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647021/
https://www.ncbi.nlm.nih.gov/pubmed/37847557
http://dx.doi.org/10.1021/acs.jcim.3c00722
_version_ 1785147482802487296
author Stevenson, Garrett A.
Kirshner, Dan
Bennion, Brian J.
Yang, Yue
Zhang, Xiaohua
Zemla, Adam
Torres, Marisa W.
Epstein, Aidan
Jones, Derek
Kim, Hyojin
Bennett, W. F. Drew
Wong, Sergio E.
Allen, Jonathan E.
Lightstone, Felice C.
author_facet Stevenson, Garrett A.
Kirshner, Dan
Bennion, Brian J.
Yang, Yue
Zhang, Xiaohua
Zemla, Adam
Torres, Marisa W.
Epstein, Aidan
Jones, Derek
Kim, Hyojin
Bennett, W. F. Drew
Wong, Sergio E.
Allen, Jonathan E.
Lightstone, Felice C.
author_sort Stevenson, Garrett A.
collection PubMed
description [Image: see text] Protein–ligand interactions are essential to drug discovery and drug development efforts. Desirable on-target or multitarget interactions are the first step in finding an effective therapeutic, while undesirable off-target interactions are the first step in assessing safety. In this work, we introduce a novel ligand-based featurization and mapping of human protein pockets to identify closely related protein targets and to project novel drugs into a hybrid protein–ligand feature space to identify their likely protein interactions. Using structure-based template matches from PDB, protein pockets are featured by the ligands that bind to their best co-complex template matches. The simplicity and interpretability of this approach provide a granular characterization of the human proteome at the protein-pocket level instead of the traditional protein-level characterization by family, function, or pathway. We demonstrate the power of this featurization method by clustering a subset of the human proteome and evaluating the predicted cluster associations of over 7000 compounds.
format Online
Article
Text
id pubmed-10647021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-106470212023-11-15 Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method Stevenson, Garrett A. Kirshner, Dan Bennion, Brian J. Yang, Yue Zhang, Xiaohua Zemla, Adam Torres, Marisa W. Epstein, Aidan Jones, Derek Kim, Hyojin Bennett, W. F. Drew Wong, Sergio E. Allen, Jonathan E. Lightstone, Felice C. J Chem Inf Model [Image: see text] Protein–ligand interactions are essential to drug discovery and drug development efforts. Desirable on-target or multitarget interactions are the first step in finding an effective therapeutic, while undesirable off-target interactions are the first step in assessing safety. In this work, we introduce a novel ligand-based featurization and mapping of human protein pockets to identify closely related protein targets and to project novel drugs into a hybrid protein–ligand feature space to identify their likely protein interactions. Using structure-based template matches from PDB, protein pockets are featured by the ligands that bind to their best co-complex template matches. The simplicity and interpretability of this approach provide a granular characterization of the human proteome at the protein-pocket level instead of the traditional protein-level characterization by family, function, or pathway. We demonstrate the power of this featurization method by clustering a subset of the human proteome and evaluating the predicted cluster associations of over 7000 compounds. American Chemical Society 2023-10-17 /pmc/articles/PMC10647021/ /pubmed/37847557 http://dx.doi.org/10.1021/acs.jcim.3c00722 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Stevenson, Garrett A.
Kirshner, Dan
Bennion, Brian J.
Yang, Yue
Zhang, Xiaohua
Zemla, Adam
Torres, Marisa W.
Epstein, Aidan
Jones, Derek
Kim, Hyojin
Bennett, W. F. Drew
Wong, Sergio E.
Allen, Jonathan E.
Lightstone, Felice C.
Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method
title Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method
title_full Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method
title_fullStr Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method
title_full_unstemmed Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method
title_short Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method
title_sort clustering protein binding pockets and identifying potential drug interactions: a novel ligand-based featurization method
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647021/
https://www.ncbi.nlm.nih.gov/pubmed/37847557
http://dx.doi.org/10.1021/acs.jcim.3c00722
work_keys_str_mv AT stevensongarretta clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT kirshnerdan clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT bennionbrianj clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT yangyue clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT zhangxiaohua clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT zemlaadam clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT torresmarisaw clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT epsteinaidan clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT jonesderek clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT kimhyojin clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT bennettwfdrew clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT wongsergioe clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT allenjonathane clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod
AT lightstonefelicec clusteringproteinbindingpocketsandidentifyingpotentialdruginteractionsanovelligandbasedfeaturizationmethod